-
Researchers to share weight loss results from bimagrumab and semaglutide combo
Steven B. Heymsfield, MD, Louis J. Aronne, MD, FACP, DABOM, and other panelists will explain insights into the treatment of obesity and overweight from BELIEVE.
-
Investigators to reveal full results from REDEFINE 1, 2 in Chicago
Melanie J. Davies, MB, ChB, MD, and other researchers will review data on combination therapy for weight loss using a fixed-dose combination of semaglutide and long-acting amylin analogue cagrilintide.